Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2026-07-02 17:16:31 ET · period of report 2026-06-30 · accession 0001193125-26-294959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:16 | 2026-06-30 | KMTS | Moran Timothy P. | Chief Business Off | A - Grant | $21.55 | +227 | 42.5K | +0.5% | +$4,892 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | A | A | 227 | $21.55 | 42,488 | D | — | — | (F1) Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026. (F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026. (F3) Includes unvested RSUs. |